Search by Drug Name or NDC
NDC 23731-7000-05 Rejuvesol .034; 1.34; .73; .311; .55 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL Details
Rejuvesol .034; 1.34; .73; .311; .55 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL
Rejuvesol is a EXTRACORPOREAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Citra Labs, LLC. The primary component is ADENINE; INOSINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PYRUVATE.
Product Information
| NDC | 23731-7000 |
|---|---|
| Product ID | 23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Rejuvesol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | EXTRACORPOREAL |
| Active Ingredient Strength | .034; 1.34; .73; .311; .55 |
| Active Ingredient Units | g/50mL; g/50mL; g/50mL; g/50mL; g/50mL |
| Substance Name | ADENINE; INOSINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PYRUVATE |
| Labeler Name | Citra Labs, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | BN950522 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23731-7000-05 (23731700005)
| NDC Package Code | 23731-7000-5 |
|---|---|
| Billing NDC | 23731700005 |
| Package | 12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5) / 50 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 1997-02-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |